Overview

Immunoassay Market is poised to value over CAGR of over 6.4% during the forecast period 2022 to 2028.

The growth in the number of infectious and chronic disease cases, increased awareness among patients pertaining to immunoassays, technological advancements in immunoassay products are some of the important factors responsible for the proliferation of the market.  

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunoassay Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Immunoassay Market.

According to the research study conducted by FutureWise research analysts, the Immunoassay Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Immunoassay Market are:

• Roche
• Abbott Laboratories
• Siemens
• Danaher
• Diasorin
• Sysmex
• Biomérieux
• Ortho Clinical Diagnostics
• Qiagen
• Thermo Fisher Scientific
• Becton, Dickinson & Company
• Bio-Rad Laboratories
• Agilent Technologies
• Mindray
• Perkinelmer

(Note: The list of the major players will be updated with the latest market scenario and trends)

Immunoassay Market Segmentation:

By Product & Service

• Reagents & Kits
    o Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
    o Rapid Test Reagents and Kits
    o Enzyme-linked immunospot ELISPOT Reagents and Kits
    o Western Blot Reagents and Kits
    o Other Reagents & Kits
• Analyzers
    o By Type
        o Open-ended Systems
        o Closed-ended systems
    o By Purchase Mode
        o Rental Purchase
        o Outright Purchase
• Software & Services

By Platform

• Chemiluminescence Immunoassays (CLIAs)
• Fluorescence Immunoassays (FIAs)
• Colorimetric Immunoassays (CIs)
• Radioimmunoassays (RIAs)
• Other Platforms

By Technology

• ELISA
  o First-generation
  o Fourth-generation & Above
  o Second-generation
  o Third-generation
• Rapid Tests
• Western Blotting
• ELISPOT
• Immuno-PCR
• Other Technologies

By Specimen

• Blood
• Saliva
• Urine
• Other Specimens

By Application

• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Hematology & Blood Screening
• Autoimmune Disorders
• Toxicology
• Neonatal Screening
• Other Applications

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs)
• Blood Banks
• Research & Academic Laboratories
• Other End Users

By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting the market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Immunoassay Market By Product & Service, By Platform, By Technology, By Specimen, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with the purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1 Objectives of the Study 
         1.2 Market Definition 
         1.3 Market Scope 
                    1.3.1 Years Considered for the Study
                    1.3.2 Market Covered
         1.4 Currency 
         1.5 Limitations 
         1.6 Stakeholders 

 2. Research Methodology 
         2.1 Research Data 
               2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
               2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
         2.2 Market Size Estimation 
         2.3 Market Breakdown and Data Triangulation 
         2.4 Assumptions for the Study 
 
3. Executive Summary

         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights

4. Global Immunoassay Market Variables, Trends & Scope

          4.1. Market Lineage Outlook
          4.2. Penetration and Growth Prospect Mapping
          4.3. Industry Value Chain Analysis
          4.4. Cost Analysis Breakdown
          4.5. Technology Overview
          4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
          5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                              5.1.1.1. Increasing focus of Biotech Companies Brand Protection
                              5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                              5.1.2.1. High Cost Associated with Implementation of CNNs
                  5.1.3. Industry Challenges
                              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Immunoassay Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies

7. By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million)
          7.1. Reagents & Kits
                 7.1.1. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
                 7.1.2. Rapid Test Reagents and Kits
                 7.1.3. Enzyme-linked immunospot ELISPOT Reagents and Kits
                 7.1.4. Western Blot Reagents and Kits
                 7.1.5. Other Reagents & Kits
          7.2. Analyzers
                 7.2.1. By Type
                          7.2.1.1. Open-ended Systems
                          7.2.1.2. Closed-ended systems
                 7.2.2. By Purchase Mode
                          7.2.2.1. Rental Purchase
                          7.2.2.2. Outright Purchase
          7.3. Software & Services

8. By Platform Historical Analysis and Forecast 2022-2028 (USD Million)
         8.1. Chemiluminescence Immunoassays (CLIAs)
         8.2. Fluorescence Immunoassays (FIAs)
         8.3. Colorimetric Immunoassays (CIs)
         8.4. Radioimmunoassays (RIAs)
         8.5. Other Platforms

9. By Technology Historical Analysis and Forecast 2022-2028 (USD Million)

         9.1. ELISA
               9.1.1. First-generation
               9.1.2. Second-generation
               9.1.3. Third-generation
               9.1.4. Fourth-generation & Above
         9.2. Rapid Tests
         9.3. Western Blotting
         9.4. ELISPOT
         9.5. Immuno-PCR
         9.6. Other Technologies

10. By Specimen Historical Analysis and Forecast 2022-2028 (USD Million)
         10.1. Blood
         10.2. Saliva
         10.3. Urine
         10.4. Other Specimens

11. By Application Historical Analysis and Forecast 2022-2028 (USD Million)
         11.1. Infectious Diseases
         11.2. Endocrinology
         11.3. Oncology
         11.4. Bone & Mineral Disorders
         11.5. Cardiology
         11.6. Haematology & Blood Screening
         11.7. Autoimmune Disorders
         11.8. Toxicology
         11.9. Neonatal Screening
         11.10. Other Applications

12. By End User Historical Analysis and Forecast 2022-2028 (USD Million)
         12.1. Hospitals
         12.2. Clinical Laboratories
         12.3. Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs)
         12.4. Blood Banks
         12.5. Research & Academic Laboratories
         12.6. Other End Users

13.  North America Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 13.2.1. U.S.A
                 13.2.2. Canada
                 13.2.3. Mexico
         13.3. Market Size (USD Million) Forecast for North America 2022-2028

14. Latin America Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
         14.1. Introduction
         14.2. Regional Market Trends
         14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                14.3.1. Brazil
                14.3.2. Venezuela
                14.3.3. Argentina
                14.3.4. Rest of Latin America
         14.4. Market Size (USD Million) Forecast for Latin America 2022-2028

15. Europe Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
         15.1. Introduction
         15.2. Historical Market Size (USD Million) Analysis By Country,   2015-2019
                  15.2.1. Germany
                  15.2.2. U.K
                  15.2.3. France
                  15.2.4. Italy
                  15.2.5. Spain
                  15.2.6. Russia
                  15.2.7. Poland
                  15.2.8. Switzerland
                  15.2.9. Romania
                  15.2.10. Rest of Western Europe
         15.3. Market Size (USD Million) Forecast for Europe 2022-2028

16. Asia Pacific Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
         16.1. Introduction
         16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 16.2.1. Japan
                 16.2.2. China
                 16.2.3. Singapore
                 16.2.4. India
                 16.2.5. Australia and New Zealand
                 16.2.6. ASEAN
                 16.2.7. South Korea
                 16.2.8. Rest of Asia Pacific
          16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028

  17. Middle East and Africa Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
          17.1. Introduction
          17.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  17.2.1. GCC
                  17.2.2. Israel
                  17.2.3. South Africa
                  17.2.4. Rest of MEA
          17.3. Market Size (USD Million) Forecast for MEA 2022-2028
      
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
          18.1 Roche
                    18.1.1 Company Overview
                    18.1.2 Financial Overview
                    18.1.3 Strategic Overview
                    18.1.4 Product Portfolio
                    18.1.5 SWOT Analysis
          18.2 Abbott Laboratories
                    18.2.1 Company Overview
                    18.2.2 Financial Overview
                    18.2.3 Strategic Overview
          18.2.4 Product Portfolio
                    18.2.5 SWOT Analysis  
          18.3 Siemens
                    18.3.1 Company Overview
                    18.3.2 Financial Overview
                    18.3.3 Strategic Overview
                    18.3.4 Product Portfolio
                    18.3.5 SWOT Analysis
          18.4. Danaher
                    18.4.1 Company Overview
                    18.4.2 Financial Overview
                    18.4.3 Strategic Overview
                    18.4.4 Product Portfolio
                    18.4.5 SWOT Analysis
          18.5. Diasorin
                    18.5.1 Company Overview
                    18.5.2 Financial Overview
                    18.5.3 Strategic Overview
                    18.5.4 Product Portfolio
                    18.5.5 SWOT Analysis
          18.6. Sysmex
                    18.6.1 Company Overview
                    18.6.2 Financial Overview
                    18.6.3 Strategic Overview
                    18.6.4 Product Portfolio
                    18.6.5 SWOT Analysis
          18.7. Biomérieux
                    18.7.1 Company Overview
                    18.7.2 Financial Overview
                    18.7.3 Strategic Overview
                    18.7.4 Product Portfolio
                    18.7.5 SWOT Analysis
          18.8. Ortho Clinical Diagnostics
                    18.8.1 Company Overview
                    18.8.2 Financial Overview
                    18.8.3 Strategic Overview
                    18.8.4 Product Portfolio
                    18.8.5 SWOT Analysis
            18.9. Qiagen
                    18.9.1 Company Overview
                    18.9.2 Financial Overview
                    18.9.3 Strategic Overview
                    18.9.4 Product Portfolio
                    18.9.5 SWOT Analysis
            18.10. Thermo Fisher Scientific
                     18.10.1 Company Overview
                     18.10.2 Financial Overview
                     18.10.3 Strategic Overview
                     18.10.4 Product Portfolio
                     18.10.5 SWOT Analysis
            18.11. Becton, Dickinson & Company
                     18.11.1 Company Overview
                     18.11.2 Financial Overview
                     18.11.3 Strategic Overview
                     18.11.4 Product Portfolio
                     18.11.5 SWOT Analysis
            18.12. Bio-Rad Laboratories
                     18.12.1 Company Overview
                     18.12.2 Financial Overview
                     18.12.3 Strategic Overview
                     18.12.4 Product Portfolio
                     18.12.5 SWOT Analysis
            18.13. Agilent Technologies
                     18.13.1 Company Overview
                     18.13.2 Financial Overview
                     18.13.3 Strategic Overview
                     18.13.4 Product Portfolio
                     18.13.5 SWOT Analysis
            18.14. Mindray
                      18.14.1 Company Overview
                      18.14.2 Financial Overview
                      18.14.3 Strategic Overview
                      18.14.4 Product Portfolio
                      18.14.5 SWOT Analysis
             18.15 Perkinelmer
                      18.15.1 Company Overview
                      18.15.2 Financial Overview
                      18.15.3 Strategic Overview
                      18.15.4 Product Portfolio
                      18.15.5 SWOT Analysis
19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME key takeaway points for Client 

Tables

Figures